The natural world is a huge source of life-saving drugs, with plants and animals providing us with all kinds of therapeutic compounds throughout human history. That extends to the sponges that inhabit the seas, with new research detailing how a molecule derived from an Indonesian sea sponge species proved capable of preventing cervical cancer growth in the lab.
from the American Thinker:
A solution to the COVID-19 epidemic is in sight. It is the combo used by South Korea, where people are back at work, to successfully stem its COVID-19 outbreak. It has three parts: (1) greatly expanded testing of those who could be infected and (2) effective treatment of the virus with a hydroxychloroquine-zinc cocktail, combined with (3) the product of American ingenuity: rapid development of vaccines.
While these solutions might be thwarted by bureaucracy, progress is happening rapidly, and there are reasons why our collective Groundhog Day of staying at home every day while the economy falters and body counts grow could soon be over.
A new study has tracked the potency of cannabis products across a number of American states, finding the majority of medical marijuana is stronger than it needs to be for pain relief purposes. The research suggests higher THC levels are unnecessary for medical uses and can increase the risk of negative side effects.
from Brent Smith for World Net Daily:
Something rather remarkable has occurred just recently regarding the Chinese/Wuhan coronavirus. And yes, I said it. Go ahead and call me a racist if you wish.
A treatment has been developed that shows promise at stopping the virus in virtually all patients for whom it’s been administered.
Early tests suggest that it can stop the virus from being contagious in just six days, with little to no side effects.
This is a huge breakthrough that’s happened in no time flat.
I stress that this appears effective as a treatment. It is not a vaccine, but if it’s as effective as advertised, it will buy the time needed to develop one.
Professor Didier Raoult from infection hospital l’Institut Hospitalo-Universitaire (IHU) Méditerranée Infection in Marseille, France, said that, “the first COVID-19 patients he had treated with the drug chloroquine had seen a rapid and effective speeding up of their healing process, and a sharp decrease in the amount of time they remained contagious.”
from Brent Smith for World Net Daily:
Will anti-Semites, like those in the “Squad,” reject a COVID-19 vaccine if it is developed by Israel?
Regarding the coronavirus, as things improve in China, things will likely worsen in America. However, they are not likely to get as bad as it is in others countries, like Italy.
But we have to be careful about comparisons. The effects of this virus are apparently amplified in the elderly and those with pre-existing health issues.
What isn’t widely publicized is that Italy’s median age is much higher than other European nations, thus it is being hit much harder than nations with younger overall populations.
by: Brent Smith
With America currently in the grip of coronavirus madness, healthcare is again front and center.
Will there be a treatment? How long will it take to develop and once it is, how long will the wait be for the administration of it once it is available?
Well, it may all depend on what country you reside in.
Many in America, especially leftists, complain about the American healthcare system. They would prefer something like, for example the Canadian system, where everyone is covered, its all free and it’s far superior to the American system.
So once a vaccine is produced, let’s all run across the border to Canada, because Canadian healthcare is great!
Or is it?
French-Canadian entrepreneur Alain Lambert has a different take on it – and it’s not quite as rosy.
They mightn’t seem like the most obvious places to look, but the venom of deadly creatures like spiders, snakes and scorpions are an increasingly rich source of medicines for human health. The latest example of this comes from scientists at Fred Hutchinson Cancer Research Center, who have discovered a tiny protein in scorpion venom that could become part of a potent new treatment for arthritis.
Scientists were close to a coronavirus vaccine years ago. Then the money dried up.
“We just could not generate much interest,” a researcher said of the difficulty in getting funding to test the vaccine in humans.
Dr. Peter Hotez, co-director of the Texas Children’s Hospital’s Center for Vaccine Development in Houston, at his lab in 2012.
HOUSTON — Dr. Peter Hotez says he made the pitch to anyone who would listen. After years of research, his team of scientists in Texas had helped develop a vaccine to protect against a deadly strain of coronavirus. Now they needed money to begin testing it in humans.